Wasting cash—the decline of the British biotech sector
暂无分享,去创建一个
Undercapitalization and overgenerous boardroom compensation for management have been major contributors to the poor performance of UK biotech.
[1] Hernan Riquelme,et al. Do Venture Capitalists' Implicit Theories on New Business Success/Failure have Empirical Validity? , 2002 .
[2] W. Bains. What you give is what you get: Investment in European biotechnology , 2006 .
[3] W. Bains. When should you fire the founder? , 2007 .
[4] W. Bains. Venture Capital and the European Biotechnology Industry , 2008 .
[5] Karl A Thiel. Goodbye Columbus! New NRDOs forego discovery , 2004, Nature Biotechnology.